Yue Lauer-Ma
Munich, BY 80336, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
LMP7 as a Target for Coronavirus Therapy: Inhibition by Ixazomib and Interaction with SARS-CoV-2 Proteins Nsp13 and Nsp16.
Journal: Pathogens (Basel, Switzerland)
Published: July 14, 2025
The CoV-Y domain of SARS-CoV-2 Nsp3 interacts with BRAP to stimulate NF-κB signaling and induce host inflammatory responses.
Journal: International journal of biological macromolecules
Published: May 24, 2024
Oxysterole-binding protein targeted by SARS-CoV-2 viral proteins regulates coronavirus replication.
Journal: Frontiers in cellular and infection microbiology
Published: February 08, 2024
Effects of immunophilin inhibitors and non-immunosuppressive analogs on coronavirus replication in human infection models.
Journal: Frontiers in cellular and infection microbiology
Published: May 31, 2022
Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication.
Journal: Antiviral research
Published: July 12, 2019
p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 14, 2016
Tubulins interact with porcine and human S proteins of the genus Alphacoronavirus and support successful assembly and release of infectious viral particles.
Journal: Virology
Published: April 25, 2016
Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir.
Journal: Virus research
Published: January 15, 2014
Virus-host interactomes--antiviral drug discovery.
Journal: Current opinion in virology
Published: August 15, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026